U.S. Molecular Diagnostics Markets for Emerging Infectious Disease Tests
U.S. Molecular Diagnostics Markets for Emerging Infectious Disease Tests
RELEASE DATE
31-Dec-2008
31-Dec-2008
REGION
North America
North America
Research Code: N46E-01-00-00-00
SKU: HC02091-NA-MR_07534
$4,950.00
In stock
SKU
HC02091-NA-MR_07534
Description
This research service analyzes the market for emerging infectious disease molecular diagnostics within the United States. The United States market was divided into the HPV molecular diagnostics and MRSA molecular diagnostics market segments.
Table of Contents
Market Overview
- Introduction
Market Overview
- Introduction
- Research Methodology
Market Segmentation and Market Sizes
- Scope and Segmentation
- Market Sizes
Market Overview
Market Challenges and Strategic Recommendations
- Introduction
- Market Engineering Measurements
Market Drivers and Restraints
- Market Challenges
- Strategic Recommendations
Market and Technology Trends
- Market Drivers
- Market Restraints
Market Forecasts
- Market Trends
- Technology Trends
Competitive Analysis
- Revenue Forecasts
Market Overview
Market Challenges and Strategic Recommendations
Market Drivers and Restraints
Market and Technology Trends
Market Forecasts
Competitive Analysis
U.S. Molecular Diagnostics Markets for Emerging Infectious Disease Tests, Decision Support Databases
Decision Support Databases
Popular Topics
This research service analyzes the market for emerging infectious disease molecular diagnostics within the United States. The United States market was divided into the HPV molecular diagnostics and MRSA molecular diagnostics market segments.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N46E-01-00-00-00 |
Is Prebook | No |